BNTX News and Press, BioNTech SE

2024-05-14 13:02:31 ET Summary Autolus Therapeutics now has years of operational runway after recent financing. Operating expenses are manageable, with numerous pipeline projects in the hopper. Autolus likely has an approved therapy on their hands, just waiting for the Novembe...

2024-05-14 11:24:32 ET More on BioNTech, Moderna, etc. BioNTech SE 2024 Q1 - Results - Earnings Call Presentation BioNTech SE (BNTX) Q1 2024 Earnings Call Transcript Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks Moderna announces del...

2024-05-10 11:15:35 ET More on Novavax Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference - (Transcript) Novavax: Another Day Older And Deeper In Novavax surges...

2024-05-08 07:06:13 ET More on AstraZeneca AstraZeneca: A Triple Shot Of Income, Growth, And Value AstraZeneca: Strong In A Weak Market AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript AstraZeneca invests $140M in Cellectis, raising stake to 44% ...

2024-05-06 14:30:16 ET Image source: The Motley Fool. BioNTech Se (NASDAQ: BNTX) Q1 2024 Earnings Call May 06, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript

2024-05-06 12:30:05 ET BioNTech SE (BNTX) Q1 2024 Earnings Conference Call May 06, 2024 08:00 AM ET Company Participants Victoria Meissner - VP, Strategy & IR Ugur Sahin - Co-Founder & CEO Ozlem Tureci - Chief Medical Officer & Co-Founder Jens Hol...

2024-05-06 11:08:32 ET More on BioNTech BioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma Company BioNTech Earnings Preview: I Will Stay On The Sidelines BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions BioNTech Q1 2024 Earn...

2024-05-06 08:26:44 ET More on pre-market losers & stocks. GameStop: Approaching An Optimistic Fair Value But Not There Yet GameStop: Operations Are Stabilizing, But Expect More Pain To Come Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript ...

2024-05-06 07:03:49 ET More on BioNTech BioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma Company BioNTech Earnings Preview: I Will Stay On The Sidelines BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions BioNTech Q1 2024 Earnin...

PRA Group Inc. (PRAA) is expected to report $-0.15 for Q1 2024 Bowman Consulting Group Ltd. (BWMN) is expected to report $-0.04 for Q1 2024 Noble Corporation plc A (NE) is expected to report $0.56 for Q1 2024 Velo3D Inc. (VLD) is expected to report for Q3 2024 Axon Enterprise Inc....